Citations (178)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (27)
Weiling Chen, Zeqi Li, Yujiao Cheng, Guijie Li, Jiaqi Li, Linhua Huang, Qiuming Gu & Houjiu Wu. (2023) Content analysis and drug safety evaluation of four furanocoumarins in six pomelos produced in China. Natural Product Research 37:23, pages 3984-3993.
Read now
Read now
Emilie R Elliot, Elisa Bisdomini, Sujan Dilly Penchala, Saye Khoo, Nneka Nwokolo & Marta Boffito. (2019) Pharmacokinetics (PK) of ethinylestradiol/levonorgestrel co-administered with atazanavir/cobicistat. HIV Research & Clinical Practice 20:3, pages 82-91.
Read now
Read now
Shuting Wang, Xiange Tang, Tingting Yang, Jiong Xu, Jiaxin Zhang, Xiaodong Liu & Li Liu. (2019) Predicted contributions of cytochrome P450s to drug metabolism in human liver microsomes using relative activity factor were dependent on probes. Xenobiotica 49:2, pages 161-168.
Read now
Read now
Maria Konstandi. (2013) Psychophysiological stress: a significant parameter in drug pharmacokinetics. Expert Opinion on Drug Metabolism & Toxicology 9:10, pages 1317-1334.
Read now
Read now
Amy Z Crepeau, Brian D Moseley & Elaine C Wirrell. (2012) Specific safety and tolerability considerations in the use of anticonvulsant medications in children. Drug, Healthcare and Patient Safety 4, pages 39-54.
Read now
Read now
N. Sekiguchi, M. Kato, M. Takada, H. Watanabe, A. Higashida, S. Sakai, M. Ishigai & Y. Aso. (2008) approach for the evaluation of mechanism-based inhibition of cytochrome P450 3A in rats. Xenobiotica 38:4, pages 368-381.
Read now
Read now
C. Emoto, H. Nishida, H. Hirai & K. Iwasaki. (2007) CYP3A4 and CYP3A5 catalyse the conversion of the -methyl-D-aspartate (NMDA) antagonist CJ-036878 to two novel dimers. Xenobiotica 37:12, pages 1408-1420.
Read now
Read now
C. Emoto & K. Iwasaki. (2007) Approach to predict the contribution of cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage: The effect of the expression of cytochrome 5 with recombinant P450 enzymes. Xenobiotica 37:9, pages 986-999.
Read now
Read now
Susan Hurst, Cho-Ming Loi, Joanne Brodfuehrer & Ayman El-Kattan. (2007) Impact of physiological, physicochemical and biopharmaceutical factors in absorption and metabolism mechanisms on the drug oral bioavailability of rats and humans. Expert Opinion on Drug Metabolism & Toxicology 3:4, pages 469-489.
Read now
Read now
C. Emoto & K. Iwasaki. (2007) Relative roles of CYP2C19 and CYP3A4/5 in midazolam 1′-hydroxylation. Xenobiotica 37:6, pages 592-603.
Read now
Read now
C. Emoto, S. Murase & K. Iwasaki. (2006) Approach to the prediction of the contribution of major cytochrome P450 enzymes to drug metabolism in the early drug-discovery stage. Xenobiotica 36:8, pages 671-683.
Read now
Read now
Jos V Castell, Ramiro Jover, Celia P Martnez-Jimnez & Mara Jos Gmez-Lechn. (2006) Hepatocyte cell lines: their use, scope and limitations in drug metabolism studies. Expert Opinion on Drug Metabolism & Toxicology 2:2, pages 183-212.
Read now
Read now
C. Emoto & K. Iwasaki. (2006) Enzymatic characteristics of CYP3A5 and CYP3A4: A comparison of kinetic and drug–drug interaction patterns. Xenobiotica 36:2-3, pages 219-233.
Read now
Read now
T. Kanazu, Y. Yamaguchi, N. Okamura, T. Baba & M. Koike. (2004) Model for the drug–drug interaction responsible for CYP3A enzyme inhibition. I: evaluation of cynomolgus monkeys as surrogates for humans. Xenobiotica 34:5, pages 391-402.
Read now
Read now
J. Venhorst, M. Rooseboom, N. P. E. Vermeulen & J. N. M. Commandeur. (2003) Studies on the inhibition of human cytochromes P450 by selenocysteine Se -conjugates. Xenobiotica 33:1, pages 57-72.
Read now
Read now
Slobodan Rendic. (2002) Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 34:1-2, pages 83-448.
Read now
Read now
D. D. Surry, G. Meneses-Lorente, R. Heavens, A. Jack & D. C. Evans. (2000) Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1. Xenobiotica 30:5, pages 441-456.
Read now
Read now
M. Nakajima, K. Kobayashi, K. Oshima, N. Shimada, S. Tokudome, K. Chiba & T. Yokoi. (1999) Activation of phenacetin O-deethylase activity by α-naphthoflavone in human liver microsomes. Xenobiotica 29:9, pages 885-898.
Read now
Read now
M. Nakajima, M. Suzuki, R. Yamaji, H. Takashina, N. Shimada, H. Yamazaki & T. Yokoi. (1999) Isoform selective inhibition and inactivation of human cytochrome P450s by methylenedioxyphenyl compounds. Xenobiotica 29:12, pages 1191-1202.
Read now
Read now
D. MCKILLOP, M. J. WILD, C. J. BUTTERS & C. SIMCOCK. (1998) Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica 28:9, pages 845-853.
Read now
Read now
H. YAMAZAKI. (1998) Formation in vitro of an inhibitory cytochrome P450·Fe2+-metabolite complex with roxithromycin and its decladinosyl, O-dealkyl and N-demethyl metabolites in rat liver microsomes. Xenobiotica 28:10, pages 995-1004.
Read now
Read now
Slobodan Rendic & Frederick J. Di Carlo. (1997) Human Cytochrome P450 Enzymes: A Status Report Summarizing Their Reactions, Substrates, Inducers, and Inhibitors. Drug Metabolism Reviews 29:1-2, pages 413-580.
Read now
Read now
Edward T. Morgan. (1997) Regulation of Cytochromes P450 During Inflammation and Infection. Drug Metabolism Reviews 29:4, pages 1129-1188.
Read now
Read now
D. F. V. LEWIS*B. G. LAKE. (1997) Molecular modelling of mammalian CYP2B isoforms and their interaction with substrates, inhibitors and redox partners. Xenobiotica 27:5, pages 443-478.
Read now
Read now
T. TERAMURA*Y. FUKUNAGA, E. J. VAN HOOGDALEM, T. WATANABE & S. HIGUCHI. (1997) Examination of metabolic pathways and identification of human liver cytochrome P450 isozymes responsible for the metabolism of barnidipine, a calcium channel blocker. Xenobiotica 27:9, pages 885-900.
Read now
Read now
D. F. V. Lewis, P. J. Eddershaw, P. S. Goldfarb & M. H. Tarbit. (1996) Molecular modelling of CYP3A4 from an alignment with CYP102: Identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica 26:10, pages 1067-1086.
Read now
Read now
D. F. V. Lewis & B. G. Lake. (1996) Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica 26:7, pages 723-753.
Read now
Read now
Articles from other publishers (151)
Eva Sanchez-Quant, Maria Lucia Richter, Maria Colomé-Tatché & Celia Pilar Martinez-Jimenez. (2023) Single-cell metabolic profiling reveals subgroups of primary human hepatocytes with heterogeneous responses to drug challenge. Genome Biology 24:1.
Crossref
Crossref
Neeraj Kumar, Jie He & James F. Rusling. (2023) Electrochemical transformations catalyzed by cytochrome P450s and peroxidases. Chemical Society Reviews 52:15, pages 5135-5171.
Crossref
Crossref
Maria Konstandi & Elizabeth O. Johnson. (2023) Age-related modifications in CYP-dependent drug metabolism: role of stress. Frontiers in Endocrinology 14.
Crossref
Crossref
Ryoto Oya, Kenji Ota, Masaaki Fuki, Yasuhiro Kobori, Masahiro Higashi, Kazunori Nagao & Hirohisa Ohmiya. (2023) Biomimetic design of an α-ketoacylphosphonium-based light-activated oxygenation auxiliary. Chemical Science.
Crossref
Crossref
Maria Konstandi, Elizabeth O. Johnson & Matti A. Lang. (2022) Stress as a Potential Regulatory Factor in the Outcome of Pharmacotherapy. Frontiers in Neuroscience 16.
Crossref
Crossref
Foteini Malliou, Christina E. Andriopoulou, Frank J. Gonzalez, Aristeidis Kofinas, Alexios-Leandros Skaltsounis & Maria Konstandi. (2021) Oleuropein-Induced Acceleration of Cytochrome P450–Catalyzed Drug Metabolism: Central Role for Nuclear Receptor Peroxisome Proliferator-Activated Receptor α. Drug Metabolism and Disposition 49:9, pages 833-843.
Crossref
Crossref
M. Saeed Mirzaei, Maxim V. Ivanov, Avat Arman Taherpour & Saber Mirzaei. (2021) Mechanism-Based Inactivation of Cytochrome P450 Enzymes: Computational Insights. Chemical Research in Toxicology 34:4, pages 959-987.
Crossref
Crossref
Ephantus J Muturi, William T Hay, Kenneth M Doll, Jose L Ramirez & Gordon Selling. (2020)
Insecticidal Activity of
Commiphora erythraea
Essential Oil and Its Emulsions Against Larvae of Three Mosquito Species
. Journal of Medical Entomology 57:6, pages 1835-1842.
Crossref
Crossref
Xuan Chen, Jiaen Zhang & Hui Wei. (2020) Physiological Responses of Earthworm Under Acid Rain Stress. International Journal of Environmental Research and Public Health 17:19, pages 7246.
Crossref
Crossref
Jyong-Huei Lee, Kuan-Lun Ho & Shih-Kang Fan. (2019) Liver microsystems in vitro for drug response. Journal of Biomedical Science 26:1.
Crossref
Crossref
Tianqi Wang, Xianjun Fu, Qingfa Chen, Jayanta Kumar Patra, Dongdong Wang, Zhenguo Wang & Zhibo Gai. (2019) Arachidonic Acid Metabolism and Kidney Inflammation. International Journal of Molecular Sciences 20:15, pages 3683.
Crossref
Crossref
Petra Zehetner, Martina Höferl & Gerhard Buchbauer. (2019) Essential oil components and cytochrome P450 enzymes: a review. Flavour and Fragrance Journal 34:4, pages 223-240.
Crossref
Crossref
Wentao Li, Wenpeng Zhang, Mengyang Chang, Juan Ren, Wenping Xie, Huiming Chen, Zhenqing Zhang, Xiaomei Zhuang, Guolin Shen & Haishan Li. (2018) Metabonomics reveals that triclocarban affects liver metabolism by affecting glucose metabolism, β-oxidation of fatty acids, and the TCA cycle in male mice. Toxicology Letters 299, pages 76-85.
Crossref
Crossref
Jonas Börgel, Lalita Tanwar, Florian Berger & Tobias Ritter. (2018) Late-Stage Aromatic C–H Oxygenation. Journal of the American Chemical Society 140:47, pages 16026-16031.
Crossref
Crossref
Jonatan Hall-Andersen, Svend G. Kaasgaard & Christian Janfelt. (2018) MALDI imaging of enzymatic degradation of glycerides by lipase on textile surface. Chemistry and Physics of Lipids 211, pages 100-106.
Crossref
Crossref
Benjamin Stenger, Adrian Gerber, Rita Bernhardt & Frank Hannemann. (2018) Functionalized poly(3-hydroxybutyric acid) bodies as new in vitro biocatalysts. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1866:1, pages 52-59.
Crossref
Crossref
Lili Zhou, Wenpeng Zhang, Wenping Xie, Huiming Chen, Wenlian Yu, Haishan Li & Guolin Shen. (2017) Tributyl phosphate impairs the urea cycle and alters liver pathology and metabolism in mice after short-term exposure based on a metabonomics study. Science of The Total Environment 603-604, pages 77-85.
Crossref
Crossref
S. Hartley, S. Pozzi-Gaudin & S. Royant-Parola. (2017) Hypersomnies rares, Modafinil ® et contraception : état des lieux et recommandations. Médecine du Sommeil 14:3, pages 151-156.
Crossref
Crossref
Tsuyoshi Ikehara, Kyoko Kuniyoshi, Naomasa Oshiro & Takeshi Yasumoto. (2017) Biooxidation of Ciguatoxins Leads to Species-Specific Toxin Profiles. Toxins 9:7, pages 205.
Crossref
Crossref
Jason D. Graci, Daniel Michaels, Guangming Chen, Gillian M. Schiralli Lester, Sarah Nodder, Marla Weetall, Gary M. Karp, Zhengxian Gu, Joseph M. Colacino & Andrew J. Henderson. (2017) Identification of benzazole compounds that induce HIV-1 transcription. PLOS ONE 12:6, pages e0179100.
Crossref
Crossref
Ayman F. El‐Kattan. 2017. Oral Bioavailability Assessment. Oral Bioavailability Assessment
35
76
.
Walter Jäger & Martina Höferl. 2015. Handbook of Essential Oils. Handbook of Essential Oils
253
279
.
Lian Yee Yip & Eric Chun Yong Chan. (2015) Investigation of Host–Gut Microbiota Modulation of Therapeutic Outcome. Drug Metabolism and Disposition 43:10, pages 1619-1631.
Crossref
Crossref
Sharad S. Lodhi, Rohit Farmer, Yogesh K. Jaiswal & Gulshan Wadhwa. (2015) In Silico Structural, Virtual Screening and Docking Studies of Human Cytochrome P450 2A7 Protein. Interdisciplinary Sciences: Computational Life Sciences 7:2, pages 129-135.
Crossref
Crossref
Victoria Tittle, Lauren Bull, Marta Boffito & Nneka Nwokolo. (2014) Pharmacokinetic and Pharmacodynamic Drug Interactions Between Antiretrovirals and Oral Contraceptives. Clinical Pharmacokinetics 54:1, pages 23-34.
Crossref
Crossref
Maria Konstandi, Elizabeth O. Johnson & Matti A. Lang. (2014) Consequences of psychophysiological stress on cytochrome P450-catalyzed drug metabolism. Neuroscience & Biobehavioral Reviews 45, pages 149-167.
Crossref
Crossref
Min Song, HyunHee Do, Oh Kwang Kwon, Eun-Ju Yang, Jong-Sup Bae, Tae Cheon Jeong, Kyung-Sik Song & Sangkyu Lee. (2014) A Comparison of the In Vitro Inhibitory Effects of Thelephoric Acid and SKF-525A on Human Cytochrome P450 Activity. Biomolecules & Therapeutics 22:2, pages 155-160.
Crossref
Crossref
Ki-Woong Kim & Yong Hyun Chung. (2013) Hepatotoxicity in Rats Treated with Dimethylformamide or Toluene or Both. Toxicological Research 29:3, pages 187-193.
Crossref
Crossref
Andreas Braun, Martina Geier, Bruno Bühler, Andreas Schmid, Stephan Mauersberger & Anton Glieder. (2012) Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes. Microbial Cell Factories 11:1.
Crossref
Crossref
Evangelos P. Daskalopoulos, Matti A. Lang, Marios Marselos, Foteini Malliou & Maria Konstandi. (2012)
D
2
-Dopaminergic Receptor-Linked Pathways: Critical Regulators of CYP3A, CYP2C, and CYP2D
. Molecular Pharmacology 82:4, pages 668-678.
Crossref
Crossref
Stephanie D. Schumacher & Joachim Jose. (2012) Expression of active human P450 3A4 on the cell surface of Escherichia coli by Autodisplay. Journal of Biotechnology 161:2, pages 113-120.
Crossref
Crossref
Evangelos P. Daskalopoulos, Foteini Malliou, Georgia Rentesi, Marios Marselos, Matti A. Lang & Maria Konstandi. (2012)
Stress is a critical player in
CYP3A
,
CYP2C
, and
CYP2D
regulation: role of adrenergic receptor signaling pathways
. American Journal of Physiology-Endocrinology and Metabolism 303:1, pages E40-E54.
Crossref
Crossref
Yongjun Zhang & Sven-Uwe Geißen. (2012) Elimination of carbamazepine in a non-sterile fungal bioreactor. Bioresource Technology 112, pages 221-227.
Crossref
Crossref
Christine M. Walko, Austin J. Combest, Ivan Spasojevic, Angela Y. C. Yu, Shriya Bhushan, J. Heyward Hull, Janelle Hoskins, Delma Armstrong, Lisa Carey, Frances Collicio & E. Claire Dees. (2012) The effect of aprepitant and race on the pharmacokinetics of cyclophosphamide in breast cancer patients. Cancer Chemotherapy and Pharmacology 69:5, pages 1189-1196.
Crossref
Crossref
Ayman El‐Kattan, Susan Hurst, Joanne Brodfuehrer & Cho‐Ming Loi. 2011. Oral Bioavailability. Oral Bioavailability
253
265
.
Kumiko Sakai-Kato, Toshiaki Hasegawa, Akio Takaoka, Masaru Kato, Toshimasa Toyo?oka, Naoko Utsunomiya-Tate & Toru Kawanishi. (2011) Controlled structure and properties of silicate nanoparticle networks for incorporation of biosystem components. Nanotechnology 22:20, pages 205702.
Crossref
Crossref
Samanta Yubero-Lahoz, Ricardo Pardo, Mag? Farr?Brian O?Mahony, Marta Torrens, Cristina Mustata, Clara P?rez-Ma??Marcell? Carb?Rafael de la Torre. (2011) Sex Differences in 3,4-Methylenedioxymethamphetamine (MDMA; Ecstasy)-Induced Cytochrome P450 2D6 Inhibition in Humans. Clinical Pharmacokinetics 50:5, pages 319-329.
Crossref
Crossref
Miriam del Carmen Carrasco-Portugal & Francisco Javier Flores-Murrieta. (2011) Gender Differences in the Pharmacokinetics of Oral Drugs. Pharmacology & Pharmacy 02:01, pages 31-41.
Crossref
Crossref
Mohammad N Uddin, Victoria F Samanidou & Ioannis N Papadoyannis. (2011) Bio-sample preparation and analytical methods for the determination of tricyclic antidepressants. Bioanalysis 3:1, pages 97-118.
Crossref
Crossref
Chie Emoto, Kazuhide Iwasaki, Ryo Koizumi, Masahiro Utoh, Norie Murayama, Yasuhiro Uno & Hiroshi Yamazaki. (2011) Species Difference between Cynomolgus Monkeys and Humans on Cytochromes P450 2D and 3A-Dependent Drug Oxidation Activities in Liver Microsomes. Journal of Health Science 57:2, pages 164-170.
Crossref
Crossref
Soyoung Lee & Dongsup Kim. (2010) Cytochrome P450 networks in chemical space. Archives of Pharmacal Research 33:9, pages 1361-1374.
Crossref
Crossref
Faith O Robert, Jagroop Pandhal & Phillip C Wright. (2010) Exploiting cyanobacterial P450 pathways. Current Opinion in Microbiology 13:3, pages 301-306.
Crossref
Crossref
Ramesh B. Bambal & Stephen E. Clarke. 2009. Evaluation of Drug Candidates for Preclinical Development. Evaluation of Drug Candidates for Preclinical Development
55
107
.
Marios Spanakis, Ioannis S. Vizirianakis, Maria Mironidou-Tzouveleki & Ioannis Niopas. (2009)
A validated SIM GC/MS method for the simultaneous determination of dextromethorphan and its metabolites dextrorphan, 3-methoxymorphinan and 3-hydroxymorphinan in biological matrices and its application to
in vitro
CYP2D6 and CYP3A4 inhibition study
. Biomedical Chromatography 23:11, pages 1131-1137.
Crossref
Crossref
Ho‐Chul Shin, Hye‐Ryoung Kim, Hee‐Jung Cho, Hee Yi, Soo‐Min Cho, Dong‐Goo Lee, A. M. Abd El‐Aty, Jin‐Suk Kim, Duxin Sun & Gordon L. Amidon. (2009) Comparative gene expression of intestinal metabolizing enzymes. Biopharmaceutics & Drug Disposition 30:8, pages 411-421.
Crossref
Crossref
Masaru Kato, Tatsuhiro Yamamoto, Masashi Sekimoto, Masakuni Degawa & Toshimasa Toyo’oka. (2009) An easy cell-based microchip assay method for a CYP1A1-mediated drug metabolism using adhesive cells, HepG2. Journal of Applied Physics 105:10.
Crossref
Crossref
. 2009. Animal Clinical Chemistry. Animal Clinical Chemistry
37
66
.
. 2009. Animal Clinical Chemistry. Animal Clinical Chemistry
17
36
.
Maria Konstandi, Dimitrios Segos, Panagiota Galanopoulou, Stamatios Theocharis, Apostolos Zarros, Matti A. Lang, Marios Marselos & Charis Liapi. (2008) Effects of choline‐deprivation on paracetamol‐ or phenobarbital‐induced rat liver metabolic response. Journal of Applied Toxicology 29:2, pages 101-109.
Crossref
Crossref
Nobuo Sekiguchi, Atsuko Higashida, Motohiro Kato, Yoshiaki Nabuchi, Tetsuya Mitsui, Kenji Takanashi, Yoshinori Aso & Masaki Ishigai. (2009) Prediction of Drug-Drug Interactions based on Time-Dependent Inhibition from High Throughput Screening of Cytochrome P450 3A4 Inhibition. Drug Metabolism and Pharmacokinetics 24:6, pages 500-510.
Crossref
Crossref
John T. Cody. 2008. Forensic Science. Forensic Science
127
174
.
Jeroen Kool, Sebastiaan M. van Liempd, Stefan Harmsen, Joran Beckman, Danny van Elswijk, Jan. N.M. Commandeur, Hubertus Irth & Nico P.E. Vermeulen. (2007) Cytochrome P450 bio-affinity detection coupled to gradient HPLC: On-line screening of affinities to cytochrome P4501A2 and 2D6. Journal of Chromatography B 858:1-2, pages 49-58.
Crossref
Crossref
Yune-Jung Yoon, Kwon-Bok Kim, Hyunmi Kim, Kyung-Ah Seo, Ho-Sook Kim, In-June Cha, Eun-Young Kim, Kwang-Hyeon Liu & Jae-Gook Shin. (2007) Characterization of Benidipine and Its Enantiomers' Metabolism by Human Liver Cytochrome P450 Enzymes. Drug Metabolism and Disposition 35:9, pages 1518-1524.
Crossref
Crossref
Olga N. Mikhailova, Lyudmila F. Gulyaeva, Maxim L. Filipenko & Vasily I. Kaledin. (2007) Enhancer elements in the mouse CYP1A2 gene: A comparative sequencing among different inbred mouse strains. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 632:1-2, pages 99-103.
Crossref
Crossref
. (2007) Formulations of Itraconazole for Topical Skin Delivery. Journal of Korean Pharmaceutical Sciences 37:3, pages 167-171.
Crossref
Crossref
Lionel D. Lewis, Antonius A. Miller, Gary L. Rosner, Jonathan E. Dowell, Manuel Valdivieso, Mary V. Relling, Merrill J. Egorin, Robert R. Bies, Donna R. Hollis, Ellis G. Levine, Gregory A. Otterson, Frederick Millard & Mark J. Ratain. (2007) A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel between African-American and Caucasian Cancer Patients: CALGB 9871. Clinical Cancer Research 13:11, pages 3302-3311.
Crossref
Crossref
Josée Michaud, Francois A. Leblond, Judith Naud, Caroline Boisvert, Karine Desbiens, Deborah A. Nicoll-Griffith & Vincent Pichette. (2007) Use of a fluorescent substrate for the selective quantification of rat CYP3A in the liver and the intestine. Journal of Pharmacological and Toxicological Methods 55:2, pages 209-213.
Crossref
Crossref
Stephanie B. Teal & David M. Ginosar. (2007) Contraception for Women with Chronic Medical Conditions. Obstetrics and Gynecology Clinics of North America 34:1, pages 113-126.
Crossref
Crossref
Jing Zhao, Aditi Das, Xiaoyu Zhang, George C. Schatz, Stephen G. Sligar & Richard P. Van Duyne. (2006) Resonance Surface Plasmon Spectroscopy: Low Molecular Weight Substrate Binding to Cytochrome P450. Journal of the American Chemical Society 128:34, pages 11004-11005.
Crossref
Crossref
Zofia Olszowy, Andrzej Plewka, Ewa Czech, Joanna Nowicka, Danuta Plewka, Grażyna Nowaczyk & Marcin Kamiński. (2006) Effect of l-carnitine supplementation on xenobiotic-metabolizing hepatic enzymes exposed to methanol. Experimental and Toxicologic Pathology 57:5-6, pages 427-435.
Crossref
Crossref
Paul Salm, Christopher Warnholtz, Jared Boyd, Lili Arabshahi, Peter Marbach & Paul J. Taylor. (2006) Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients. Clinical Biochemistry 39:7, pages 732-738.
Crossref
Crossref
Y. Simarro Doorten, S. Nijmeijer, L. de Nijs-Tjon & J. Fink-Gremmels. (2006) Metabolism-mediated Ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay. Food and Chemical Toxicology 44:2, pages 261-270.
Crossref
Crossref
Kumiko Sakai-Kato, Masaru Kato, Hiroshi Homma, Toshimasa Toyo'oka & Naoko Utsunomiya-Tate. (2005) Creation of a P450 Array toward High-throughput Analysis. Analytical Chemistry 77:21, pages 7080-7083.
Crossref
Crossref
Eva M Vasquez, Grace P Shin, Nicole Sifontis & Enrico Benedetti. (2005) Concomitant Clotrimazole Therapy More Than Doubles the Relative Oral Bioavailability of Tacrolimus. Therapeutic Drug Monitoring 27:5, pages 587-591.
Crossref
Crossref
. (2005) FFPRHC Guidance (April 2005) Drug interactions with hormonal contraception. Journal of Family Planning and Reproductive Health Care 31:2, pages 139-150.
Crossref
Crossref
Akihiko Saitoh, Kumud K Singh, Christine A Powell, Terrence Fenton, Courtney V Fletcher, Richard Brundage, Stuart Starr & Stephen A Spector. (2005) An MDR1-3435 variant is associated with higher plasma nelfinavir levels and more rapid virologic response in HIV-1 infected children. AIDS 19:4, pages 371-380.
Crossref
Crossref
Stewart B. Kirton, Christopher W. Murray, Marcel L. Verdonk & Richard D. Taylor. (2005) Prediction of binding modes for ligands in the cytochromes P450 and other heme-containing proteins. Proteins: Structure, Function, and Bioinformatics 58:4, pages 836-844.
Crossref
Crossref
Chie Emoto, Shigeo Murase, Yasufusa Sawada & Kazuhide Iwasaki. (2005) In Vitro Inhibitory Effect of 1-Aminobenzotriazole on Drug Oxidations in Human Liver Microsomes: a Comparison with SKF-525A. Drug Metabolism and Pharmacokinetics 20:5, pages 351-357.
Crossref
Crossref
Gail D. Anderson. (2005) Sex and Racial Differences in Pharmacological Response: Where Is the Evidence? Pharmacogenetics, Pharmacokinetics, and Pharmacodynamics. Journal of Women's Health 14:1, pages 19-29.
Crossref
Crossref
Donghak Kim & F. Peter Guengerich. (2004) Enhancement of 7-methoxyresorufin O-demethylation activity of human cytochrome P450 1A2 by molecular breeding. Archives of Biochemistry and Biophysics 432:1, pages 102-108.
Crossref
Crossref
Iv??n Saavedra, Jorge Le??n, Jaime Prado, M. Pilar S??nchez, Fernando L??pez & Leonardo Gaete. (2004) A Comparative Pharmacokinetic Study of Micronized Estradiol Valerate Administered Alone and in Combination with Medroxyprogesterone Acetate in Postmenopausal Women. Therapeutic Drug Monitoring 26:5, pages 482-485.
Crossref
Crossref
G. Iohom, D. Fitzgerald & A.J. Cunningham. (2004) Principles of pharmacogenetics—implications for the anaesthetist. British Journal of Anaesthesia 93:3, pages 440-450.
Crossref
Crossref
Hongbing Wang, Stephanie Faucette, Rick Moore, Tatsuya Sueyoshi, Masahiko Negishi & Edward LeCluyse. (2004) Human Constitutive Androstane Receptor Mediates Induction of CYP2B6 Gene Expression by Phenytoin. Journal of Biological Chemistry 279:28, pages 29295-29301.
Crossref
Crossref
Motonobu Furukawa, Masuhiro Nishimura, Daisuke Ogino, Ryoji Chiba, Iwao Ikai, Nobuhiko Ueda, Shinsaku Naito, Shunji Kuribayashi, Mohsen A. Moustafa, Takafumi Uchida, Hideki Sawada, Tetsuya Kamataki, Yoshihiko Funae & Manabu Fukumoto. (2005)
Cytochrome P450
gene expression levels in peripheral blood mononuclear cells in comparison with the liver
. Cancer Science 95:6, pages 520-529.
Crossref
Crossref
Martijn Rooseboom, Jan N. M. Commandeur & Nico P. E. Vermeulen. (2004) Enzyme-Catalyzed Activation of Anticancer Prodrugs. Pharmacological Reviews 56:1, pages 53-102.
Crossref
Crossref
Alison de Souza, Susan Brechin & Gillian Penney. (2004) The members' enquiry service: frequently asked questions. Journal of Family Planning and Reproductive Health Care 30:1, pages 57-58.
Crossref
Crossref
Toshimasa TanakaNaomi KamiguchiTeruaki OkudaYoshio Yamamoto. (2004) Characterization of the CYP2C8 Active Site by Homology Modeling. Chemical and Pharmaceutical Bulletin 52:7, pages 836-841.
Crossref
Crossref
J. Strandell, A. Neil & G. Carlin. (2004) An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine 11:2-3, pages 98-104.
Crossref
Crossref
A. Wayne Jones. 2004. Handbook of Drug Interactions. Handbook of Drug Interactions
395
462
.
Dmitry Korolev, Konstantin V. Balakin, Yuri Nikolsky, Eugene Kirillov, Yan A. Ivanenkov, Nikolay P. Savchuk, Andrey A. Ivashchenko & Tatiana Nikolskaya. (2003) Modeling of Human Cytochrome P450-Mediated Drug Metabolism Using Unsupervised Machine Learning Approach. Journal of Medicinal Chemistry 46:17, pages 3631-3643.
Crossref
Crossref
Richard Hockett & Sandra Kirkwood. 2003. Biomarkers in Clinical Drug Development. Biomarkers in Clinical Drug Development.
Chongwoo Yu, Young Geun Shin, Jerome W. Kosmeder, John M. Pezzuto & Richard B. van Breemen. (2003) Liquid chromatography/tandem mass spectrometric determination of inhibition of human cytochrome P450 isozymes by resveratrol and resveratrol‐3‐sulfate. Rapid Communications in Mass Spectrometry 17:4, pages 307-313.
Crossref
Crossref
Milan Zdravkovic, Anette K. Olsen, Tina Christiansen, Rainer Schulz, Mitchell E. Taub, Mikael S. Thomsen, Michael H. Rasmussen & Mapoko M. Ilondo. (2003) A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate. European Journal of Clinical Pharmacology 58:10, pages 683-688.
Crossref
Crossref
M. Teresa Donato & Jos?? V. Castell. (2003) Strategies and Molecular Probes to Investigate the Role of Cytochrome P450 in Drug Metabolism. Clinical Pharmacokinetics 42:2, pages 153-178.
Crossref
Crossref
Chie Emoto, Shigeo Murase, Yasufusa Sawada, Barry C. Jones & Kazuhide Iwasaki. (2003) In Vitro Inhibitory Effect of 1-Aminobenzotriazole on Drug Oxidations Catalyzed by Human Cytochrome P450 Enzymes: A Comparison with SKF-525A and Ketoconazole. Drug Metabolism and Pharmacokinetics 18:5, pages 287-295.
Crossref
Crossref
Stefan Laufer, Gerd Wagner & Dunja Kotschenreuther. (2002) Ones, Thiones, andN-Oxides: An Exercise in Imidazole Chemistry. Angewandte Chemie International Edition 41:13, pages 2290-2293.
Crossref
Crossref
Stefan Laufer, Gerd Wagner & Dunja Kotschenreuther. (2002) One, Thione undN-Oxide: ein allgemeiner Zugang zu Imidazolderivaten. Angewandte Chemie 114:13, pages 2408-2411.
Crossref
Crossref
Richard D. Hockett, Sandra C. Kirkwood, Bruce H. Mitlak & Willard H. Dere. (2002) Pharmacogenomics in Endocrinology. The Journal of Clinical Endocrinology & Metabolism 87:6, pages 2495-2499.
Crossref
Crossref
Paul Salm, Paul J. Taylor, Stephen V. Lynch & Peter I. Pillans. (2002) Quantification and stability of everolimus (SDZ RAD) in human blood by high-performance liquid chromatography?electrospray tandem mass spectrometry. Journal of Chromatography B 772:2, pages 283-290.
Crossref
Crossref
A Shemer, G Weiss & H Trau. (2002) Oral terbinafine in the treatment of onychomycosis: a comparison of continuous and extended‐pause regimens. Journal of the European Academy of Dermatology and Venereology 16:3, pages 299-301.
Crossref
Crossref
Nobumitsu Hanioka, Shogo Ozawa, Hideto Jinno, Toshiko Tanaka-Kagawa, Tetsuji Nishimura, Masanori Ando & Jun-ichi Sawada. (2002) Interaction of Irinotecan (CPT-11) and Its Active Metabolite 7-Ethyl-10-Hydroxycamptothecin (SN-38) with Human Cytochrome P450 Enzymes. Drug Metabolism and Disposition 30:4, pages 391-396.
Crossref
Crossref
Philip N. Patsalos, Walter Fröscher, Francesco Pisani & Clementina M. Van Rijn. (2002) The Importance of Drug Interactions in Epilepsy Therapy. Epilepsia 43:4, pages 365-385.
Crossref
Crossref
Miki Nakajima, Kazuhiro Tane, Sumika Nakamura, Noriaki Shimada, Hiroshi Yamazaki & Tsuyoshi Yokoi. (2002) Evaluation of Approach to Predict the Contribution of Multiple Cytochrome P450s in Drug Metabolism Using Relative Activity Factor: Effects of the Differences in Expression Levels of NADPH–Cytochrome P450 Reductase and Cytochrome b5 in the Expression System and the Differences in the Marker Activities. Journal of Pharmaceutical Sciences 91:4, pages 952-963.
Crossref
Crossref
Yoshiaki Kawashima, Mieko Hagiwara, Yoshimasa Inoue & Toshiyuki Someya. (2002) Evaluation of Dextromethorphan N‐Demethylation Activity as a Biomarker for Cytochrome P450 3A Activity in Man. Pharmacology & Toxicology 90:2, pages 82-88.
Crossref
Crossref
Cristina Rodr?guez-Antona, M.Teresa Donato, Eugenia Pareja, Maria-Jos? G?mez-Lech?n & Jos? V. Castell. (2001) Cytochrome P-450 mRNA Expression in Human Liver and Its Relationship with Enzyme Activity. Archives of Biochemistry and Biophysics 393:2, pages 308-315.
Crossref
Crossref
David Lewis. 2001. Guide to Cytochromes P450. Guide to Cytochromes P450
164
210
.
Vaughn Miller & Charles Crespi. 2001. Handbook of Drug Screening. Handbook of Drug Screening.
Ilona Kariv, Mark P. Fereshteh & Kevin R. Oldenburg. (2001) Development of a Miniaturized 384-Well High Throughput Screen for the Detection of Substrates of Cytochrome P450 2D6 and 3A4 Metabolism. SLAS Discovery 6:2, pages 91-99.
Crossref
Crossref
Dieter Schrenk, Petra R. Baus, Nadine Ermel, Christopher Klein, Birgit Vorderstemann & Hans-Martin Kauffmann. (2001) Up-regulation of transporters of the MRP family by drugs and toxins. Toxicology Letters 120:1-3, pages 51-57.
Crossref
Crossref
Agn?s Tran, Jean-Marc Tr?luyer, Elisabeth Rey, Jacques Barbet, G?raldine Ferracci, Philippe d'Athis, Jean Vincent & G?rard Pons. (2001) Protective Effect of Stiripentol on Acetaminophen-Induced Hepatotoxicity in Rat. Toxicology and Applied Pharmacology 170:3, pages 145-152.
Crossref
Crossref
Pascal Bonnabry, Johann Sievering, Thierry Leemann & Pierre Dayer. (2001) Quantitative Drug Interactions Prediction System (Q-DIPS). Clinical Pharmacokinetics 40:9, pages 631-640.
Crossref
Crossref
Sheila J. Sadeghi, Georgia E. Tsotsou, Michael Fairhead, Yergalem T. Meharenna & Gianfranco Gilardi. 2000. Physics and Chemistry Basis of Biotechnology. Physics and Chemistry Basis of Biotechnology
71
104
.
Anne K. Ellis & James H. Day. (2008) Second‐ and third‐generation antihistamines in the treatment of urticaria. Dermatologic Therapy 13:4, pages 327-336.
Crossref
Crossref
Jennifer Venhorst, Rob C.A Onderwater, John H.N Meerman, Nico P.E Vermeulen & Jan N.M Commandeur. (2000) Evaluation of a novel high-throughput assay for cytochrome P450 2D6 using 7-methoxy-4-(aminomethyl)-coumarin. European Journal of Pharmaceutical Sciences 12:2, pages 151-158.
Crossref
Crossref
Sebastian Härtter. (2000) In vitro Methoden zur Untersuchung des Phase-I Metabolismus. Pharmazie in unserer Zeit 29:6, pages 365-371.
Crossref
Crossref
VAUGHN P. MILLER, DAVID M. STRESSER, ANDREW P. BLANCHARD, STEPHANIE TURNER & CHARLES L. CRESPI. (2006) Fluorometric High-Throughput Screening for Inhibitors of Cytochrome P450. Annals of the New York Academy of Sciences 919:1, pages 26-32.
Crossref
Crossref
Charles L. Crespi & David M. Stresser. (2000) Fluorometric screening for metabolism-based drug–drug interactions. Journal of Pharmacological and Toxicological Methods 44:1, pages 325-331.
Crossref
Crossref
Poolsup, Li Wan Po & Knight. (2000) Pharmacogenetics and psychopharmacotherapy. Journal of Clinical Pharmacy and Therapeutics 25:3, pages 197-220.
Crossref
Crossref
Cristina Rodr?guez-Antona, Ramiro Jover, Maria-Jos? G?mez-Lech?n & Jos? V. Castell. (2000) Quantitative RT-PCR Measurement of Human Cytochrome P-450s: Application to Drug Induction Studies. Archives of Biochemistry and Biophysics 376:1, pages 109-116.
Crossref
Crossref
J. J. Miceli, R. J. Anziano, L. Robarge, R. A. Hansen & A. Laurent. (2001) The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers. British Journal of Clinical Pharmacology 49:S1, pages 65-70.
Crossref
Crossref
K. D. Wilner, S. B. Demattos, R. J. Anziano, G. Apseloff & N. Gerber. (2001) Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers. British Journal of Clinical Pharmacology 49:S1, pages 43-47.
Crossref
Crossref
John T. Cody. 2000. Forensic Science. Forensic Science
107
141
.
Nathalie Chauret, Nathalie Tremblay, Rebecca L. Lackman, Jacques-Yves Gauthier, Jos? M. Silva, Jean Marois, James A. Yergey & Deborah A. Nicoll-Griffith. (1999) Description of a 96-Well Plate Assay to Measure Cytochrome P4503A Inhibition in Human Liver Microsomes Using a Selective Fluorescent Probe. Analytical Biochemistry 276:2, pages 215-226.
Crossref
Crossref
Katz. (1999) Drug interactions of the newer oral antifungal agents. British Journal of Dermatology 141:s56, pages 26-32.
Crossref
Crossref
Harry V Gelboin, Kristopher W Krausz, Frank J Gonzalez & Tian J Yang. (1999) Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery. Trends in Pharmacological Sciences 20:11, pages 432-438.
Crossref
Crossref
Lew. (1999) Review article: pharmacokinetic concerns in the selection of anti-ulcer therapy. Alimentary Pharmacology & Therapeutics 13, pages 11-16.
Crossref
Crossref
David R Hawkins. (1999) Use and value of metabolism databases. Drug Discovery Today 4:10, pages 466-471.
Crossref
Crossref
Jean-Michel Linget & Pierre du Vignaud. (1999) Automation of metabolic stability studies in microsomes, cytosol and plasma using a 215 Gilson liquid handler. Journal of Pharmaceutical and Biomedical Analysis 19:6, pages 893-901.
Crossref
Crossref
F. Peter Guengerich. (1999) CYTOCHROME P-450 3A4: Regulation and Role in Drug Metabolism. Annual Review of Pharmacology and Toxicology 39:1, pages 1-17.
Crossref
Crossref
Anastacio M. Hoyumpa, Hector Trevino-Alanis, Imogene Grimes & Thomas J. Humphries. (1999) Rabeprazole: Pharmacokinetics in patients with stable, compensated cirrhosis. Clinical Therapeutics 21:4, pages 691-701.
Crossref
Crossref
Wayne Hooper. 1999. Handbook of Drug Metabolism. Handbook of Drug Metabolism
229
238
.
P. N. Patsalos. 1999. Antiepileptic Drugs. Antiepileptic Drugs
553
587
.
Marion L. Williams, Irving W. Wainer, Leanne Embree, Michael Barnett, Camille L. Granvil & Murray P. Ducharme. (1999) Enantioselective induction of cyclophosphamide metabolism by phenytoin. Chirality 11:7, pages 569-574.
Crossref
Crossref
Ram P Gupta & Mohamed B Abou-Donia. (1998) Cytochrome P450 enzymes in chickens: characteristics and induction by xenobiotics. Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 121:1-3, pages 73-83.
Crossref
Crossref
Paul J Taylor & Anthony G Johnson. (1998) Quantitative analysis of sirolimus (Rapamycin) in blood by high-performance liquid chromatography?electrospray tandem mass spectrometry. Journal of Chromatography B: Biomedical Sciences and Applications 718:2, pages 251-257.
Crossref
Crossref
F Fontaine, G de Sousa, P Duchene & R Rahmani. (1998) Cytochrome P450 Induction and Cytotoxic effects of Antimalarials in Rat Hepatocytes. Toxicology in Vitro 12:5, pages 545-549.
Crossref
Crossref
Renke Dai, Suoping Zhai, Xiaoxiong Wei, Matthew R. Pincus, Robert E. Vestal & Fred K. Friedman. (1998) Inhibition of human cytochrome P450 1A2 by flavones: A molecular modeling study. Journal of Protein Chemistry 17:7, pages 643-650.
Crossref
Crossref
H.Irving Katz. (1998) Systemic antifungal agents used to treat onychomycosis. Journal of the American Academy of Dermatology 38:5, pages S48-S52.
Crossref
Crossref
James Leyden. (1998) Pharmacokinetics and pharmacology of terbinafine and itraconazole. Journal of the American Academy of Dermatology 38:5, pages S42-S47.
Crossref
Crossref
Angela D.M. Kashuba, Joseph S. Bertino, Gregory L. Kearns, J. Steven Leeder, Alan W. James, Russell Gotschall & Anne N. Nafziger. (1998) Quantitation of three-month intraindividual variability and influence of sex and menstrual cycle phase on CYP1A2, N-acetyltransferase-2, and xanthine oxidase activity determined with caffeine phenotyping*. Clinical Pharmacology & Therapeutics 63:5, pages 540-551.
Crossref
Crossref
Richard C. Zangar & Raymond F. Novak. (1998) Posttranslational Elevation of Cytochrome P450 3A Levels and Activity by Dimethyl Sulfoxide. Archives of Biochemistry and Biophysics 353:1, pages 1-9.
Crossref
Crossref
Tian J Yang, Magang Shou, Kenneth R Korzekwa, Frank J Gonzalez, Harry V Gelboin & Shen K Yang. (1998) Role of cDNA-Expressed Human Cytochromes P450 in the Metabolism of Diazepam. Biochemical Pharmacology 55:6, pages 889-896.
Crossref
Crossref
Hani Zaher, Tian J Yang, Harry V Gelboin, Pedro Fernandez-Salguero & Frank J Gonzalez. (1998) Effect of Phenobarbital on Hepatic CYP1A1 and CYP1A2 in the Ahr-Null Mouse. Biochemical Pharmacology 55:2, pages 235-238.
Crossref
Crossref
Toshiharu Sakai, Toshio Teramura, Hideaki Okamiya & Osamu Inagaki. (2007) A Review on Barnidipine: A Novel Calcium Antagonist. Cardiovascular Drug Reviews 15:4, pages 273-290.
Crossref
Crossref
Hiroshi Yamazaki & Tsutomu Shimada. (1997) Human liver cytochrome P450 enzymes involved in the 7-hydroxylation of R- and S-warfarin enantiomers. Biochemical Pharmacology 54:11, pages 1195-1203.
Crossref
Crossref
Marcel Delaforge, François Andre, Maryse Jaouen, Hugues Dolgos, Henri Benech, Jean‐Marie Gomis, Jean‐Pierre Noel, Florine Cavelier, Jean Verducci, Jean‐Louis Aubagnac & Bernd Liebermann. (2004)
Metabolism of Tentoxin by Hepatic Cytochrome
P
‐450 3A Isozymes
. European Journal of Biochemistry 250:1, pages 150-157.
Crossref
Crossref
Robert T. Dorr. (2012) Pharmacology of the Taxanes. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:5P2.
Crossref
Crossref
H. Irving Katz & Aditya K. Gupta. (1997) ORAL ANTIFUNGAL DRUG INTERACTIONS. Dermatologic Clinics 15:3, pages 535-544.
Crossref
Crossref
Carmen Valenzuela, Eva Delp?n, Laura Franqueza, Pilar Gay, Javier Vicente & Juan Tamargo. (1997) Comparative effects of nonsedating histamine H1 receptor antagonists, ebastine and terfenadine, on human Kv1.5 channels. European Journal of Pharmacology 326:2-3, pages 257-263.
Crossref
Crossref
Charles L. Crespi, Vaughn P. Miller & Bruce W. Penman. (1997) Microtiter Plate Assays for Inhibition of Human, Drug-Metabolizing Cytochromes P450. Analytical Biochemistry 248:1, pages 188-190.
Crossref
Crossref
Richard C. Zangar, Marissa Hernandez & Raymond F. Novak. (1997) Posttranscriptional Elevation of Cytochrome P450 3A Expression. Biochemical and Biophysical Research Communications 231:1, pages 203-205.
Crossref
Crossref
Costas Ioannides. 1997. Molecular and Cellular Pharmacology. Molecular and Cellular Pharmacology
1013
1032
.
Charles L. Crespi & Bruce W. Penman. 1997.
171
188
.
P. Olinga, D.K.F. Meijer, M.J.H. Slooff & G.M.M. Groothuis. (1997) Liver slices in in vitro pharmacotoxicology with special reference to the use of human liver tissue. Toxicology in Vitro 12:1, pages 77-100.
Crossref
Crossref
STACY C. EDGE, JOHN S. MARKOWITZ & C. LINDSAY DEVANE. (1997) Clozapine Drug-Drug Interactions: A Review of the Literature. Human Psychopharmacology: Clinical and Experimental 12:1, pages 5-20.
Crossref
Crossref
KR BALSON, DJ MORGAN, BH RICHMOND, ME McALINDON, SL ELLIOTT & ND YEOMANS. (2008) Sedation for Endoscopy. Journal of Gastroenterology and Hepatology 11:12, pages 1177-1180.
Crossref
Crossref
John H. Cavanaugh & Michael D. Karol. (2013) Lack of Pharmacokinetic Interaction after Administration of Lansoprazole or Omeprazole with Prednisone. The Journal of Clinical Pharmacology 36:11, pages 1064-1071.
Crossref
Crossref
Raimo Kekkonen, Oskari Heikinheimo, Erik Mandelin & Pekka Lähteenmäki. (1996) Pharmacokinetics of mifepristone after low oral doses. Contraception 54:4, pages 229-234.
Crossref
Crossref
Jurgen Schmider, David J. Greenblatt, Lisa L. von Moltke & Richard I. Shader. (1996) Relationship of In Vitro Data on Drug Metabolism to In Vivo Pharmacokinetics and Drug Interactions. Journal of Clinical Psychopharmacology 16:4, pages 267-272.
Crossref
Crossref
D. Müller, R. Glöckner & M. Rost. (1996) Monooxygenation, cytochrome P4501A1 and P4501A1-mRNA in rat liver slices exposed to beta-naphthoflavone and dexamethasone in vitro. Experimental and Toxicologic Pathology 48:5, pages 433-438.
Crossref
Crossref
Margit Spatzenegger, Gerhard Ecker & Walter J?ger. (1996) Determination of the New MDR-Modifier PFP 6 and its Metabolites in Human Liver Microsomes by High-Performance Liquid Chromatography. Biomedical Chromatography 10:3, pages 127-130.
Crossref
Crossref